A Study of Brentuximab Vedotin With Doxorubicin, Vinblastine and Dacarbazine in Adults With Hodgkin Lymphoma in India

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE4

מצבים רפואיים

Hodgkin Lymphoma

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • HCG City Cancer Centre, Vijayawada, Andhra Pradesh, India

    Contact: Study coordinator (Site Contact) · drpolisetty.a@hcgel.com · 9611165090
    Contact: Principal Investigator (Amarnath Polishetty)
  • Gauhati Medical college and Hospital, Guwahati, Assam, India

  • Unique Hospital Multispeciality and Research Institute, Surat, Gujarat, India

    Contact: Study coordinator (Site Contact) · tanveermaksud@gmail.com · 9909918887
    Contact: Principal Investigator (Tanveer Maksud)
  • HCG Cancer Centre, Bangalore, Karnataka, India

    Contact: Study coordinator (Site Contact) · drnatarajks@gmail.com · 9482141773
    Contact: Principal Investigator (Natraj KS)
  • JIPMER, Puducherry, Kerala, India

  • HCG Manavata Cancer Centre, Nashik, Maharashtra, India

  • ACTREC, Navi Mumbai, Maharashtra, India

  • DMH, Pune, Maharashtra, India

  • Rajiv Gandhi Cancer Hospital, Delhi, New Delhi, India

  • NRS Medical college & Hospital, Kolkata, Kolkata, West Bengal, India

    Contact: Study coordinator (Site Contact) · tkdolai@hotmail.com · 9874890275
    Contact: Principal Investigator (Tuphan kanti Dolai)
  • AIIMS, New Delhi, India

    Contact: Study coordinator (Site Contact) · ajaygogia@gmail.com · 9013000642
    Contact: Principal Investigator (Ajay Gogia)